Basel Medical (BMGL) Invested Capital (2024 - 2025)
Basel Medical (BMGL) has disclosed Invested Capital for 2 consecutive years, with $4.2 million as the latest value for Q2 2025.
- Quarterly Invested Capital fell 51.65% to $4.2 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $4.2 million through Jun 2025, down 51.65% year-over-year, with the annual reading at $4.2 million for FY2025, 51.65% down from the prior year.
- Invested Capital hit $4.2 million in Q2 2025 for Basel Medical, down from $8.7 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $8.7 million in Q2 2024 to a low of $4.2 million in Q2 2025.